DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin: This impact of gender is important to consider for the complement system, since dysf-/- female SJL/J mice were used in the study that reported downregulation of decay accelerating factor /CD55 [43], and fatty replacement of many muscles is more severe in female patients with dysferlinopathy [16].